Literature DB >> 10777240

Predicting which patients will develop chronic critical leg ischemia.

J Dormandy1, L Heeck, S Vig.   

Abstract

Although numerically far less than claudicants, patients with critical leg ischemia (CLI) demand a disproportionately large commitment both in medical effort and economically and represent the major workload for vascular surgical units. The incidence and prevalence of CLI is approximately 500 to 1,000/million/year. The risk factors for the development of CLI are largely the same as those for the progression of local disease in IC, the most important, apart from age, being smoking and diabetes. Major amputation is more common amongst claudicants who are heavy smokers and who continue to smoke, and although stopping smoking slows down the vascular changes and reduces the likelihood of symptomatic progression, it does not reduce the risk of major amputation over the following 2 to 3 years. Diabetic PAOD patients are about 10 times more likely to come to amputation than nondiabetic PAOD patients, and the prevalence of gangrene is 20 to 30 times higher in individuals with diabetes and PAOD compared with nondiabetics with PAOD. There is some evidence that most of these effects of risk factors are additive.

Entities:  

Mesh:

Year:  1999        PMID: 10777240

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  11 in total

1.  Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Authors:  Michael P Murphy; Jeffrey H Lawson; Brian M Rapp; Michael C Dalsing; Janet Klein; Michael G Wilson; Gary D Hutchins; Keith L March
Journal:  J Vasc Surg       Date:  2011-04-22       Impact factor: 4.268

2.  Characteristics of peripheral arterial disease in Japanese type 2 diabetic patients.

Authors:  S Gorogawa; O Iida; M Ikeda; T Watarai; M Kubota; S Nanto; H Kaneto; Y Yamasaki
Journal:  Diabetologia       Date:  2006-04-06       Impact factor: 10.122

3.  Prevalence of peripheral arterial disease - results of the Heinz Nixdorf recall study.

Authors:  Knut Kröger; Andreas Stang; Jana Kondratieva; Susanne Moebus; Eva Beck; Axel Schmermund; Stefan Möhlenkamp; Nico Dragano; Johannes Siegrist; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

4.  X-ray-visible microcapsules containing mesenchymal stem cells improve hind limb perfusion in a rabbit model of peripheral arterial disease.

Authors:  Dorota A Kedziorek; Lawrence V Hofmann; Yingli Fu; Wesley D Gilson; Kenyatta M Cosby; Bernard Kohl; Brad P Barnett; Brian W Simons; Piotr Walczak; Jeff W M Bulte; Kathleen Gabrielson; Dara L Kraitchman
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

5.  Diabetes status differentiates endothelial function and plasma nitrite response to exercise stress in peripheral arterial disease following supervised training.

Authors:  Jason D Allen; Thomas Stabler; Aarti A Kenjale; Katherine L Ham; Jennifer L Robbins; Brian D Duscha; William E Kraus; Brian H Annex
Journal:  J Diabetes Complications       Date:  2013-12-17       Impact factor: 2.852

Review 6.  Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Authors:  Sergio Coccheri
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Plasma nitrite response and arterial reactivity differentiate vascular health and performance.

Authors:  Jason D Allen; Elizabeth M Miller; Earl Schwark; Jennifer L Robbins; Brian D Duscha; Brian H Annex
Journal:  Nitric Oxide       Date:  2009-01-25       Impact factor: 4.427

8.  Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease.

Authors:  Raul J Guzman; D Marshal Brinkley; Paul M Schumacher; Rafe M J Donahue; Holly Beavers; Xiao Qin
Journal:  J Am Coll Cardiol       Date:  2008-05-20       Impact factor: 24.094

9.  Stem cell therapy for critical limb ischaemia - a review.

Authors:  Anjan Kumar Das
Journal:  Indian J Surg       Date:  2009-09-02       Impact factor: 0.656

10.  Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach.

Authors:  Rouven Berndt; Lars Hummitzsch; Katharina Heß; Martin Albrecht; Karina Zitta; Rene Rusch; Beke Sarras; Andreas Bayer; Jochen Cremer; Fred Faendrich; Justus Groß
Journal:  Stem Cell Res Ther       Date:  2018-04-27       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.